Abstract:Objective To detect the expressions of E-cadherin, α-catenin and β-catenin and analyze the relationship between E-cadherin-catenin adhesion complex and clinicopathological features in breast cancer. Methods The expressions of E-cadherin, α-cadherin and β-catenin in specimens of 54 breast cancer, 21 normal breast tissues around tumor, 15 breast hyperplasia of usual type and 15 breast atypical hyperplasia were detected by immunohistochemical method. Results In 21 normal breast tissues, E-cadherin and α-catenin were expressed on cell membrane of ductal and acinic cells, showing cellular contour and border among cells. The staining character of the three proteins in breast hyperplasia of usual type was the same as that in normal breast tissue. In breast atypical hyperplasia, the abnormal expression rates of E-cadherin, α-catenin and β-catenin were 6.7%, 13.3% and 26.7%, respectively. The total abnormal expression rate of E-cadherin-catenin complex was 33.3%. In breast cancer, the abnormal expression rates of E-cadherin, α-catenin and β-catenin were 51.9%, 63.0% and 61.1%, respectively. The total abnormal expression rate of E-cadherin-catenin complex was 88.9%. Abnormal expression of E-cadherin and α-catenin were significantly correlated with histological grade. Abnormal expressions of α-catenin and β-catenin were significantly correlated with TNM staging, axillary lymph nodes metastasis and postoperative distant metastasis. Abnormal expression of E-cadherin-catenin complex was correlated with TNM staging, histological grade and axillary lymph nodes. Abnormal expression of β-catenin was negatively correlated with expression of HER-2. COX multiple factor analysis showed that E-cadherin or α-catenin or β-catenin was not independent prognostic indicator. Conclusion Abnormal expressions of E-cadherin, α-catenin and β-catenin frequently occur in breast cancer. Abnormal expression of E-cadherin-catenin complex is correlated with differentiation disturbance and metastasis. Combined measurement of E-caherin, α-catenin and β-catenin may improve accuracy and sensitivity of predicting metastasis and prognosis of breast cancer.

Expression of Β-Catenin, Cyclin D1 and ERα in Breast Cancer

The Expression of Estrogen Receptor Α, Β in Different Breast Tissues and Its Relation with Breast Cancer

Β-Catenin Expression:The Role in Carcinogenesis and Development of Human Breast Cancer

The expressing signification of estrogen receptorβ in breast cancer

[High Expression of Cyclin D1 is Correlated with the Expression of Estrogen Receptor and Good Prognosis in Breast Cancer].

Expression of β-catenin and cyclinD1 in human pancreatic carcinoma and significance

Expression of E-cadherin, β-catenin and Cyclin D1 in gastric adenocarcinoma and their clinical significances

Expression of E-cadherin/catenin Complex in Breast Cancer

Expression and Clinical Significance of FPARγ and Β-Catenin in Breast Cancer

Expression of P16,β-Catenin, CyclinD1 in Cervical Lesions and Their Clinical Significance

Expression of E-cadherin, Beta-Catenin, Cathepsin D, Gelatinases and Their Inhibitors in Invasive Ductal Breast Carcinomas

Expression of Β-Catenin and Cyclind1 in Biliary Tumors and Its Clinical Significance

[Abnormal Expression of Beta-Catenin and E-cadherin in Her2-positive Breast Cancer and Its Implications].

Expression and CD147,MMP-9 and P-Erk in Invasive Ductal Carcinoma of Breast and Its Significance

Expression of β-catenin, cyclin D1 and c-myc in colorectal carcinoma

[Expression and Clinical Significance of Beclin1 and PTEN in Endometrial Carcinoma].

Expression of Cyclin G in Breast Cancer Tissue

Clinical Implications of Β-Catenin Protein Expression in Breast Cancer.

Expression and clinical significance of β-catenin in breast cancer tissue

[Differential Expression of Cyclins D1, E and A in Human Breast Diseases].

Association of different patterns of expression of beta-catenin and cyclin D1 with pathogenesis of breast carcinoma